Pengfei Shao

2.0k total citations
84 papers, 1.4k citations indexed

About

Pengfei Shao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Pengfei Shao has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 37 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Pengfei Shao's work include Renal cell carcinoma treatment (23 papers), Renal and Vascular Pathologies (17 papers) and Cancer-related molecular mechanisms research (9 papers). Pengfei Shao is often cited by papers focused on Renal cell carcinoma treatment (23 papers), Renal and Vascular Pathologies (17 papers) and Cancer-related molecular mechanisms research (9 papers). Pengfei Shao collaborates with scholars based in China, France and Chile. Pengfei Shao's co-authors include Chao Qin, Changjun Yin, Xiaoxin Meng, Xiaobing Ju, Qiang Cao, Pu Li, Qiang Lv, Hongzhou Cai, Lijun Tang and Jie Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Pengfei Shao

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengfei Shao China 22 738 576 411 174 143 84 1.4k
Alexander H. Boag Canada 16 710 1.0× 505 0.9× 138 0.3× 179 1.0× 375 2.6× 40 1.5k
Tatsuo Igarashi Japan 23 476 0.6× 821 1.4× 232 0.6× 478 2.7× 300 2.1× 95 1.5k
Jiandong Zhang China 17 424 0.6× 343 0.6× 237 0.6× 144 0.8× 258 1.8× 79 1.1k
Kyungeun Kim South Korea 22 510 0.7× 316 0.5× 217 0.5× 256 1.5× 352 2.5× 87 1.2k
Hakmin Lee South Korea 20 441 0.6× 594 1.0× 174 0.4× 318 1.8× 288 2.0× 95 1.3k
Vijay Joshi United States 21 763 1.0× 301 0.5× 614 1.5× 667 3.8× 229 1.6× 57 2.5k
Yongsheng Song China 20 577 0.8× 285 0.5× 459 1.1× 85 0.5× 187 1.3× 47 1.0k
Jeffrey E. Thatcher United States 12 1.5k 2.0× 208 0.4× 989 2.4× 384 2.2× 117 0.8× 24 2.4k
Xiangshan Fan China 25 553 0.7× 563 1.0× 242 0.6× 409 2.4× 501 3.5× 141 1.8k
Qingquan Luo China 27 489 0.7× 925 1.6× 350 0.9× 343 2.0× 413 2.9× 146 2.0k

Countries citing papers authored by Pengfei Shao

Since Specialization
Citations

This map shows the geographic impact of Pengfei Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Shao more than expected).

Fields of papers citing papers by Pengfei Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Shao. The network helps show where Pengfei Shao may publish in the future.

Co-authorship network of co-authors of Pengfei Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Shao. A scholar is included among the top collaborators of Pengfei Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Shao. Pengfei Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Bao, et al.. (2024). LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy. European journal of medical research. 29(1). 103–103. 5 indexed citations
2.
Shao, Pengfei, et al.. (2024). Flexible Ureteroscopic Holmium Laser Lithotripsy vs Percutaneous Nephrolithotomy for Renal Stones. International Journal of Pharmacology. 20(4). 593–601.
3.
Dong, Yiwei, et al.. (2023). Deformation characterization method of typical double-walled turbine blade structure during casting process. Journal of Iron and Steel Research International. 30(10). 2010–2020. 28 indexed citations
4.
Liang, Chao, Lei Ding, Meiling Bao, et al.. (2022). A comprehensive prostate biopsy standardization system according to quantitative multiparametric MRI and PSA value: P.R.O.S.T score. World Journal of Urology. 40(9). 2245–2253. 1 indexed citations
5.
Sun, Shengjie, Tao Yan, Junchen Li, et al.. (2020). Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis. BMC Medical Genetics. 21(1). 139–139. 14 indexed citations
6.
Wang, Tingting, Yi Xu, Pengfei Shao, et al.. (2019). Measurement of Glomerular Filtration Rate Using Multiphasic Computed Tomography in Patients With Unilateral Renal Tumors: A Feasibility Study. Frontiers in Physiology. 10. 1209–1209. 4 indexed citations
7.
Liu, Yiyang, Jian Qian, Meiling Bao, et al.. (2015). miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells. DNA and Cell Biology. 34(6). 429–436. 58 indexed citations
9.
Huang, Yuan, Gong Cheng, Bianjiang Liu, et al.. (2014). A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients. BMC Urology. 14(1). 8–8. 11 indexed citations
10.
Cao, Qiang, Jian Wang, Pu Li, et al.. (2014). Genetic Variants in RKIP Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population. PLoS ONE. 9(10). e109285–e109285. 10 indexed citations
11.
Zhao, Ruizhe, Yuan Huang, Gong Cheng, et al.. (2014). Developing a Follow-Up Strategy for Patients with PSA Ranging from 4 to 10 ng/ml via a New Model to Reduce Unnecessary Prostate Biopsies. PLoS ONE. 9(9). e106933–e106933. 5 indexed citations
12.
Xu, Yi, Pengfei Shao, Xiaomei Zhu, et al.. (2013). Three-dimensional renal CT angiography for guiding segmental renal artery clamping during laparoscopic partial nephrectomy. Clinical Radiology. 68(11). e609–e616. 23 indexed citations
13.
Chen, Jiawei, Xinhai Cui, Hai Zhou, et al.. (2013). Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study. BMC Cancer. 13(1). 356–356. 22 indexed citations
14.
Zhu, Chen, Pengfei Shao, Meiling Bao, et al.. (2013). miR-154 inhibits prostate cancer cell proliferation by targeting CCND2. Urologic Oncology Seminars and Original Investigations. 32(1). 31.e9–31.e16. 51 indexed citations
15.
Chen, Jiawei, Pengfei Shao, Qiang Cao, et al.. (2012). Genetic Variations in a PTEN/AKT/mTOR Axis and Prostate Cancer Risk in a Chinese Population. PLoS ONE. 7(7). e40817–e40817. 33 indexed citations
16.
Chen, Jiawei, Yi‐Long Wu, Pengfei Shao, et al.. (2011). Association Between VHL Single Nucleotide Polymorphism (rs779805) and the Susceptibility to Prostate Cancer in Chinese. DNA and Cell Biology. 31(5). 790–796. 7 indexed citations
17.
Shao, Pengfei, Qi Ding, Chao Qin, et al.. (2011). Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. The Prostate. 71(10). 1122–1130. 15 indexed citations
18.
Zhang, Wei, et al.. (2010). Laparoscopic extraperitoneal radical prostatectomy. Zhonghua miniao waike zazhi. 31(3). 199–202.
19.
Shao, Pengfei, Changjun Yin, Xiaoxin Meng, et al.. (2010). Retroperitoneal laparoscopic partial nephrectomy for the treatment of renal tumor. Zhonghua miniao waike zazhi. 31(10). 658–661. 1 indexed citations
20.
Shao, Pengfei, Chao Qin, Changjun Yin, et al.. (2010). Laparoscopic Partial Nephrectomy With Segmental Renal Artery Clamping: Technique and Clinical Outcomes. European Urology. 59(5). 849–855. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026